SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Zydus Lifesciences to subscribe equity shares of Torrent Urja 26, Torrent Urja 25

29 May 2025 Evaluate

Zydus Lifesciences has entered into Share Subscription and Shareholders’ Agreement (SSSA) on May 28, 2025, to subscribe to equity shares of Torrent Urja 26. In line with the commitment to enhance the share of renewable power source in its operations and to comply with regulatory requirement for being a ‘captive user’ under Electricity Act, 2003, the Company has entered into SSSA to acquire up to 26.20% equity shares of Torrent Urja 26, for setting up captive hybrid power project in Gujarat.

Further, Zydus Lifesciences and its various subsidiaries have also entered into SSSAs on May 28, 2025, to subscribe to equity shares of Torrent Urja 25. In line with the commitment to enhance the share of renewable power source in its operations and to comply with regulatory requirement for being a ‘captive user’ under Electricity Act, 2003, the Company and its various subsidiaries have entered into SSSAs to acquire up to 22.06% equity shares of Torrent Urja 25, for setting up captive hybrid power project in Gujarat.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.

Zydus Lifesciences Share Price

936.00 12.90 (1.40%)
15-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.65
Dr. Reddys Lab 1218.30
Cipla 1226.65
Zydus Lifesciences 936.00
Lupin 2339.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×